Vascular endothelial cell growth factor antagonists
    57.
    发明申请
    Vascular endothelial cell growth factor antagonists 审中-公开
    血管内皮细胞生长因子拮抗剂

    公开(公告)号:US20020098187A1

    公开(公告)日:2002-07-25

    申请号:US10104427

    申请日:2002-03-21

    Abstract: The present invention provides human vascular endothelial cell growth factor (hVEGF) antagonists, including monoclonal antibodies, hVEGF receptors, and hVEGF variants that are useful for the treatment of age-related macular degeneration, and other diseases and disorders characterzied by undesirable or excessive neovascularization.

    Abstract translation: 本发明提供了人类血管内皮细胞生长因子(hVEGF)拮抗剂,包括可用于治疗年龄相关性黄斑变性的单克隆抗体,hVEGF受体和hVEGF变体,以及由不想要的或过度的新生血管形成特征的其它疾病和病症。

Patent Agency Ranking